Status: Available
Managed Access Programs for INC424, Ruxolitinib
The purpose of this registration is to list Managed Access Programs (MAPs) related to INC424, Ruxolitinib
Trial details
Age: 2+Biological sex: AllType: Expanded AccessSponsor: Novartis PharmaceuticalsUpdated: Nov 18, 2025
Eligibility criteria
An independent request was received from a licensed physician. [+6]